167 related articles for article (PubMed ID: 18706905)
1. Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women.
Bartholomeusz CF; Wesnes KA; Kulkarni J; Vitetta L; Croft RJ; Nathan PJ
Horm Behav; 2008 Nov; 54(5):684-93. PubMed ID: 18706905
[TBL] [Abstract][Full Text] [Related]
2. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
Yaffe K; Vittinghoff E; Ensrud KE; Johnson KC; Diem S; Hanes V; Grady D
Arch Neurol; 2006 Jul; 63(7):945-50. PubMed ID: 16831962
[TBL] [Abstract][Full Text] [Related]
3. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.
Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA
Menopause; 2006; 13(3):411-22. PubMed ID: 16735938
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans.
Green A; Ellis KA; Ellis J; Bartholomeusz CF; Ilic S; Croft RJ; Phan KL; Nathan PJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):575-84. PubMed ID: 15936063
[TBL] [Abstract][Full Text] [Related]
5. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
[TBL] [Abstract][Full Text] [Related]
6. The beneficial effects of estradiol on attentional processes are dependent on timing of treatment initiation following ovariectomy in middle-aged rats.
Bohacek J; Daniel JM
Psychoneuroendocrinology; 2010 Jun; 35(5):694-705. PubMed ID: 19926225
[TBL] [Abstract][Full Text] [Related]
7. Reproductive events modify the effects of estrogen replacement therapy on cognition in healthy postmenopausal women.
Dunkin J; Rasgon N; Wagner-Steh K; David S; Altshuler L; Rapkin A
Psychoneuroendocrinology; 2005 Apr; 30(3):284-96. PubMed ID: 15511602
[TBL] [Abstract][Full Text] [Related]
8. Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.
Schiff R; Bulpitt CJ; Wesnes KA; Rajkumar C
Psychoneuroendocrinology; 2005 May; 30(4):309-15. PubMed ID: 15694110
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women.
Krug R; Born J; Rasch B
Psychoneuroendocrinology; 2006 Sep; 31(8):965-75. PubMed ID: 16831520
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.
Gibbs RB; Burke AM; Johnson DA
Horm Behav; 1998 Oct; 34(2):112-25. PubMed ID: 9799622
[TBL] [Abstract][Full Text] [Related]
12. Estradiol or estradiol/progesterone treatment in older women: no strong effects on cognition.
Wolf OT; Heinrich AB; Hanstein B; Kirschbaum C
Neurobiol Aging; 2005 Jul; 26(7):1029-33. PubMed ID: 15748783
[TBL] [Abstract][Full Text] [Related]
13. The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory.
Wilson WL; Munn C; Ross RC; Harding JW; Wright JW
Brain Res; 2009 May; 1272():25-31. PubMed ID: 19328191
[TBL] [Abstract][Full Text] [Related]
14. Effects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humans.
Nathan PJ; Tanner S; Lloyd J; Harrison B; Curran L; Oliver C; Stough C
Hum Psychopharmacol; 2004 Mar; 19(2):91-6. PubMed ID: 14994318
[TBL] [Abstract][Full Text] [Related]
15. The effect of 3-year treatment with 0.25 mg/day of micronized 17beta-estradiol on cognitive function in older postmenopausal women.
Pefanco MA; Kenny AM; Kaplan RF; Kuchel G; Walsh S; Kleppinger A; Prestwood K
J Am Geriatr Soc; 2007 Mar; 55(3):426-31. PubMed ID: 17341247
[TBL] [Abstract][Full Text] [Related]
16. Scopolamine induced deficits in a battery of rat cognitive tests: comparisons of sensitivity and specificity.
Hodges DB; Lindner MD; Hogan JB; Jones KM; Markus EJ
Behav Pharmacol; 2009 May; 20(3):237-51. PubMed ID: 19436198
[TBL] [Abstract][Full Text] [Related]
17. The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.
Liem-Moolenaar M; Zoethout RW; de Boer P; Schmidt M; de Kam ML; Cohen AF; Franson KL; van Gerven JM
J Psychopharmacol; 2010 Nov; 24(11):1671-9. PubMed ID: 20142308
[TBL] [Abstract][Full Text] [Related]
18. The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine.
Fredrickson A; Snyder PJ; Cromer J; Thomas E; Lewis M; Maruff P
Hum Psychopharmacol; 2008 Jul; 23(5):425-36. PubMed ID: 18421801
[TBL] [Abstract][Full Text] [Related]
19. The effects of scopolamine and cyclizine on visual-vestibular interaction in humans.
Gowans J; Matheson A; Darlington CL; Smith PF
J Vestib Res; 2000; 10(2):87-92. PubMed ID: 10939683
[TBL] [Abstract][Full Text] [Related]
20. Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance.
Conley AC; Albert KM; McDonald BC; Saykin AJ; Dumas JA; Newhouse PA
Hum Psychopharmacol; 2022 Sep; 37(5):e2838. PubMed ID: 35212023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
